WordNet

the management of someone or something; "the handling of prisoners"; "the treatment of water sewage"; "the right to equal treatment in the criminal justice system" (同)handling
care provided to improve a situation (especially medical procedures or applications that are intended to relieve illness or injury) (同)intervention
a manner of dealing with something artistically; "his treatment of space borrows from Italian architecture"

PrepTutorEJDIC

〈U〉(人・物の)『取り扱い』,扱い方《+of+名》 / 〈U〉治療;〈C〉(…に対する)治療法《+for+名》

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. アルコール使用障害の心理社会的治療 psychosocial treatment of alcohol use disorder
2. 統合失調症に対する心理社会的介入 psychosocial interventions for schizophrenia
3. 成人におけるコカイン関連疾患の治療 treatment of cocaine use disorder in adults
4. 重度の精神疾患の心理社会的介入 psychosocial interventions for severe mental illness
5. 女性のオルガスム障害の治療 treatment of female orgasmic disorder

English Journal

Improved virological suppression in children on antiretroviral treatment receiving community-based adherence support: A multicentre cohort study from South Africa.

Fatti G, Shaikh N, Eley B, Grimwood A.Author information a Kheth'Impilo , Cape Town , South Africa.AbstractAdherence to antiretroviral treatment (ART) is a challenge in childhood, and children on ART have reduced virological suppression compared to adults. This study evaluated the effect of community-based adherence support (CBAS) on virological outcomes amongst children receiving ART in four South African provinces. Patient Advocates are lay CBAS workers who provide adherence and psychosocial support for patients, undertaking home visits to address household challenges affecting adherence. Patient Advocates provide counselling for children's carers regarding adherence and psychosocial problems. A multicentre cohort study using routinely collected data was conducted at 57 public ART sites including ART-naive children (<16 years) starting ART. Virological suppression until four years of ART was compared between children who received and did not receive CBAS. Analyses were by intention-to-treat, controlling for confounding using multivariable generalised estimating equations. A total of 4853 children were included, of whom 982 (20.2%) received CBAS. The median baseline age was 6.3 years and the baseline CD4 cell percentage was 12.0%; both were equivalent between the two groups. CBAS children had more advanced baseline clinical disease (62.1% vs. 52.6% World Health Organisation stages III or IV; P < 0.0001). A total of 5908 viral load results were analysed. Virological suppression was 65.6% (95% confidence interval [CI]: 62.7-68.4%) vs. 55.5% (95% CI: 54.1-57.0%) in CBAS and non-CBAS children, respectively, at any time-point on treatment (P < 0.0001). In analyses controlling for baseline clinical, demographic, site-related variables and time on ART, children receiving CBAS were more likely to achieve virological suppression, adjusted odds ratio (aOR) 1.60 (95% CI: 1.35-1.89; P < 0.0001). The effect of CBAS increased in magnitude with increasing durations of ART, and CBAS particularly improved virological suppression in a higher-risk subgroup (children younger than two years, aOR 2.47 [95% CI: 1.59-3.84]). CBAS was associated with improved virological suppression in children receiving ART. Expanded implementation of this low-cost intervention should be considered in resource-poor settings.
AIDS care.AIDS Care.2014 Apr;26(4):448-53. doi: 10.1080/09540121.2013.855699. Epub 2013 Nov 11.
Adherence to antiretroviral treatment (ART) is a challenge in childhood, and children on ART have reduced virological suppression compared to adults. This study evaluated the effect of community-based adherence support (CBAS) on virological outcomes amongst children receiving ART in four South Afric
PMID 24215157

Illness perceptions, coping styles and psychological distress in adults with Huntington's disease.

Arran N, Craufurd D, Simpson J.Author information a Department of Neuropsychology , Salford Royal Hospital NHS Foundation Trust , Salford , UK.AbstractIndividuals with a diagnosis of Huntington's disease (HD) have been shown to experience various emotional, behavioural and psychosocial consequences. The current study employs Leventhal's self-regulation model to explore the biopsychosocial factors related to psychological distress in people with HD, and further examine the relationship between illness perceptions, coping and psychological distress. Eighty-seven people diagnosed with HD completed the Illness Perceptions Questionnaire-Revised adapted for the population. Participants also completed self-report measures of coping and psychological distress. Data were also collected on clinical and demographic variables previously found to be associated with psychological distress. Hierarchical multiple regression analyses demonstrated that illness perceptions of identity, treatment control and timeline cyclical were predictors of anxiety while illness perceptions of identity and perceiving the cause to be related to chance were found to be significant positive predictors of depression. The coping strategy of seeking instrumental support also contributed to scores of depression, and self-report clinical variables of pain and role functioning related to physical difficulties predicted anxiety and depression, respectively. The findings suggest that illness perceptions play a significant role in psychological distress experienced by people with HD. Consequently, a focus on interventions which might change illness perceptions, and perhaps then reduce psychological distress, would be useful for future research.
Psychology, health & medicine.Psychol Health Med.2014 Apr;19(2):169-79. doi: 10.1080/13548506.2013.802355. Epub 2013 Jun 14.
Individuals with a diagnosis of Huntington's disease (HD) have been shown to experience various emotional, behavioural and psychosocial consequences. The current study employs Leventhal's self-regulation model to explore the biopsychosocial factors related to psychological distress in people with HD
PMID 23767964

Prevalence and correlates of smoking status among Veterans Affairs primary care patients with probable Major Depressive Disorder.

Lombardero A1, Campbell DG2, Harris KJ3, Chaney EF4, Lanto AB5, Rubenstein LV6.Author information 1Department of Psychology, The University of Montana, 32 Campus Drive, Missoula, MT 59812, United States. Electronic address: anayansilombardero@gmail.com.2Department of Psychology, The University of Montana, 32 Campus Drive, Missoula, MT 59812, United States.3School of Public and Community Health Sciences, The University of Montana, 32 Campus Drive, Missoula, MT 59812, United States.4VA Puget Sound Healthcare System, 1660 S Columbian Way, Seattle, WA 98108, United States; University of Washington School of Medicine, Warren G. Magnuson Health Sciences Center, Box 356340, 1925 N.E. Pacific Street Seattle, WA 98195-6340, United States.5VA Greater Los Angeles Healthcare System, 11301 Wilshire Blvd #6005, Los Angeles, CA 90073, United States.6VA Greater Los Angeles Healthcare System, 11301 Wilshire Blvd #6005, Los Angeles, CA 90073, United States; RAND Health Program, 1776 Main Street, P.O. Box 2138, Santa Monica, CA 90407, United States.AbstractIn an attempt to guide planning and optimize outcomes for population-specific smoking cessation efforts, the present study examined smoking prevalence and the demographic, clinical and psychosocial characteristics associated with smoking among a sample of Veterans Affairs primary care patients with probable major depression. Survey data were collected between 2003 and 2004 from 761 patients with probable major depression who attended one of 10 geographically dispersed VA primary care clinics. Current smoking prevalence was 39.8%. Relative to nonsmokers with probable major depression, bivariate comparisons revealed that current smokers had higher depression severity, drank more heavily, and were more likely to have comorbid PTSD. Smokers with probable major depression were also more likely than nonsmokers with probable major depression to have missed a health care appointment and to have missed medication doses in the previous 5months. Smokers were more amenable than non-smokers to depression treatment and diagnosis, and they reported more frequent visits to a mental health specialist and less social support. Alcohol abuse and low levels of social support were significant concurrent predictors of smoking status in controlled multivariable logistic regression. In conclusion, smoking prevalence was high among primary care patients with probable major depression, and these smokers reported a range of psychiatric and psychosocial characteristics with potential to complicate systems-level smoking cessation interventions.
Addictive behaviors.Addict Behav.2014 Mar;39(3):538-45. doi: 10.1016/j.addbeh.2013.10.030. Epub 2013 Nov 4.
In an attempt to guide planning and optimize outcomes for population-specific smoking cessation efforts, the present study examined smoking prevalence and the demographic, clinical and psychosocial characteristics associated with smoking among a sample of Veterans Affairs primary care patients with
PMID 24290879

Japanese Journal

ストレス関連疾患としての摂食障害

心身医学 57(8), 797-804, 2017
NAID 130005876426

Evaluation of growth hormone treatment efficacy in short Japanese children born small for gestational age: Five-year treatment outcome and impact on puberty